VIRUSMYTH HOMEPAGE
Res. Immunol.
Paris 1990
1990, 141, 815-838
NON-HIV IMMUNOSUPPRESSIVE FACTORS IN AIDS:
A MULTIFACTORIAL, SYNERGISTIC THEORY OF AIDS AETIOLOGY
R.S. Root-Bernstein
Department of Physiology, Michigan State University,
East Lansing, MI 48824 (USA)
Recent evidence has begun to indicate that HIV (human immunodeficiency
virus) is neither a sufficient nor a necessary cause of acquired immunedeficiency
syndrome (AIDS). Lemaitre, et al. (1990) reported that tetracycline
obviates HIV pathogenicity, leading Montaigner to suggest that a cofactor
such as a mycoplasma infection may be necessary to trigger HIV cytocidal
activity and replication. This observation may confirm earlier claims by
Lo (Lo,1986; Lo et al. ,1989; Wright, 1990) that mycoplasmas may
play an essential role in AIDS pathogenesis. Similar data has also been
reported from Gallo's laboratory by Lusso et al., demonstrating
that the rate of HIV replication and its cytocidal effects are determined
by coinfection of cells with herpes viruses (Lusso et al., 1989)
and other retroviruses (Lusso et al.,1990).
Indeed, Groopman has noted that cytomegalovirus (CMV), adenoviruses
and hepatitis B virus (HBV) can also potentiate the cytotoxic effect of
HIV in vitro, but maintains that these interactions have no proven
bearing on the clinical picture of AIDS (Wright, 1990). His assessment
is not, in fact, accurate. CMV superinfection of HIV-positive haemopheliacs
has been shown to increase their probability of developing AIDS by almost
4-fold over CMV-negative, HIV-positive controls (Webster et al.,
1989) and synergistic effects of CMV on Candida, Staphylococcus and
Pseudomonas infections cause increased mortality in mice (Hamilton
et al., 1976).
Similarly, human patients having multiple infections, such as combined
CMV, HBV and Epstein-Barr virus (EBV), develop such more severe symptoms
than typical CMV mononucleosis patients (Oill et al., 1977). Synergism
between hepatitis C virus (HCV) and HIV leading to enhanced infection and
mortality has been reported in mother-infant transmission of AIDS (Giovannini
et al., 1990). And almost all AIDS patients who develop demyelinating
dementias have combined CMV and Mycobacterial infections, which
differentiates them significantly from non-demented patients (Root-Bernstein,
1990a). These data strongly suggest that HIV is not sufficient to cause
AIDS; or, at the very least, that the rate at which HIV infection causes
disease is determined by immunosuppressive cofactors.
Epidemiological findings support this conclusion. The distribution of
HIV positivity is equal between men and women ages 17 to 19 in the United
States and has been so for the past six years (Burke et al., 1990).
If HIV were suffiicient to cause AIDS, then AIDS should affect men and
women in their mid-twenties (heterosexuals, bisexuals and homosexuals)
equally. Clearly, it does not (CDC, 1989a,b).
The necessity of HIV infection in AIDS has also been brought into question
by reports of the syndrome or its preceding manifestations in HIV-negative
individuals. Haemophiliacs develop immune deficiencies of equal magnitudes
and involving the same T-cell subsets whether they are HIV-positive or
not (Jin et al., 1989). A 1982 study of heroin addicts found that
24 % had T4/T8 ratios typical of AIDS patients as well as defects in E-rosette
formation. When retested in 1985, only 12 % were HIV-positive (Donohoe
et al., 1987, suggesting that profound immunosuppression preceded
HIV infection rather than resulting from it. The only controlled study
of blood transfusions that I have been able to locate indicates that 50
% of patients receiving HIV-tainted blood died within a year, and also
that 50 % of "recipients of components from a random selection of
donors not known to be infected with HIV, died in the year after transfusion"
(Ward et al., 1989), again suggesting that HIV is an insignificant
cause of morbìdity and mortality among both HIV-infected and HIV-negative
patients. Longterm studies of HIV-negative patients were, unfortunately,
not performed to validate or falsify this conclusion. More than a dozen
HIV-negative homosexual men have developed Kaposi's sarcoma (KS) (Friedman-Kein,1990
; Lowdell,1989 ; Afrasiabi,1986 ; Muret et al. ,1990).
And several cases of chronic oral or oesophageal candidiasis and immune
thromobocytopenia accompanied by low CD4+ T-cell counts in HIV-negative
patients without known causes of immunosuppression have also been reported
(Parkhurst and Peakman, 1989; Gatenby, 1989; Daus et al., 1989).
It is impossible to determine how prevalent HIV-negative AIDS cases are
at present since existing data are inadequate. Five percent of AIDS patients
tested for HIV do not demonstrate the presence of antibody or virus and
only about 50 % of all AIDS patients in the United States have ever been
tested for HIV antibody (CDC, 1989). Since the surveillance definition
of AIDS does not require an HIV-positive antibody test, but only the presence
of an opportunistic infection in the absence of certain defimed causes
of immunosuppression (CDC, 1987), it is possible that a considerable number
of HIV-negative AIDS cases exist and that many physicians assume HIV infection
without adequate evidence. The existence of even a handful of such cases
is, in any event, sufficient logically to doubt the necessity of HIV as
a cause of AIDS.
It is therefore essential that the non-HIV immunosuppressive agents
be reevaluated as possible cofactors for HIV or, in some combination, as
possible causes of AIDS in the absence of HIV. We must, in other words,
consider a multifactorial, synergistic aetiology for AIDS.
I have recently completed a literature review of non-HIV immunosuppressive
factors associated with AIDS (Root-Bernstein, 1990b). I found that every
AIDS patient has some subset of established immunosuppressive agents at
work that include, but are not limited to: immunological contact with semen
components (Mathur et al., 1981; Mavligit et al., 1984) ;
recreational drugs such as the nitrites (Lotzova et al., 1984 ;
Brambilla, 1985) ; addictive drugs such as the opiates and cocaine (Brown
et al., 1974; Weber and Pert, 1989); multiple, concurrent infections
with viruses, bacteria, amoeba, protozoa and/or fungi (Rouse and Horohov,
1986; Mella, 1967; Smith, 1985; Hartung et al., 1979); malnutrition dueto
any of several causes including malabsorption syndrome associated with
"gay bowel syndrome" (Yardley and Hendrix, 1980) ; the indirect
results of drug addiction, anorexia and poverty (Chandra, 1983 ; Dowd and
Heatley, 1984; Pifer et al., 1987); anaesthetics (Tsuda and Kahan,
1983); chronic antibiotic use (Munster et al., 1977; Pifer et
al., 1987); blood transfusions (Salveteirra et al., 1980; Fischer
et al., 1980; Thomas et al., 1983); and blood factor treatment
(Bedall et al., 1985; Pollack et al., 1985; McPherson et
al., 1986).
While none of these agents are sufficiently immunosuppressive in and
of themselves (with the possible exceptions: massive blood transfusion,
prolonged i.v. drug use and severe malnutrition) to account for the profound
problems associated with AIDS, a combination of several of them acting
synergistically would certainly be sufficient. Notably CMV infections (Oill
et al., 1977; Carney et al., 1981), EBV infections (Weigle
et al., 1983), mycobacterial infections (Beck et al., 1985;
Shiratsuchi and Tsuyuguchi, 1984), blood transfusions (Kaplan et al.,
1984), a combination of surgery with anaesthetics (Hole and Dakke, 1984),
opiates (Donohoe et al., 1986; 1987) and malnutrition (Chandra et
al., 1982) have each been demonstrated in the absence of HIV infection
to cause the abnormal T4/T8 lymphocyte ratio and the diminished natural
killer cell activity typical of AIDS patients. Since each of these agents
occurs with high frequency (and often in various combinations with the
others) in AIDS patients, the exclusive attribution of AIDS-related T-cell
subset abnormalities to HIV is inaccurate. On the contrary, it is necessary
to recognize that every AIDS patient has multiple, concurrent causes of
immunosuppression in addition to, and sometimes in the absence of, HIV-infection
(Root-Bernstein, 1990b).
Recognition of the importance of non-HIV immunosuppressive agents as
aetiological agents in AIDS requires concomitant recognition that infection
by HIV is not the only factor that distinguishes AIDS risk groups from
non-risk groups. I have therefore predicted that in HIV-positive individuals
development to full-blown AIDS will depend upon the number and intensity
of non-HIV immunosuppressive agents also at work in that individual, and
therefore that the rate of disease progression may vary from extremely
fast (a few months) for those repeatedly exposed to intense, multiple immunosuppressive
factors, to infinitely long (a lifetime) for those who incur none of the
listed immunosuppressive agents. It is also probable that AIDS can be induced
in HIV-negative individuals by a concordance of several of these non-HIV
immunosuppressive agents or, alternatively, prevented in HIV-positive individuals
by eliminating these factors or controlling their effects (Root-Bernstein,
1990b).
The recognition of immunosuppression by non-HIV factors in AIDS also
requires rethinking of and researching into much of what we have taken
for granted about AIDS. If some combination of such factors is sufficient
to cause AIDS in the absence of HIV, then several conclusions follow. One
is that AIDS should not be a new syndrome, since most of the immunosuppressive
agents listed above are not, themselves, new. That prediction is, in fact,
correct. Several dozen cases of Pneumocystis pneumonia, CMV infections
and other opportunistic diseases in Western European and North American
patients matching the CDC surveillance definition of AIDS have been reported
by Huminer and his colleagues (1987; 1988) ; Katner and Pankey (1987) found
28 cases of KS between 1902 and 1978 satisfying the definition of AIDS;
and I have recently reported the existence of several hundred further cases
of KS dating back as far as Kaposi's first paper of 1872 that also satisfy
the CDC surveillance definition of AIDS (Root-Bernstein, 1990c).
These are just the tip of an apparently unsuspected iceberg. Hundreds
of cases of other opportunistic infections satisfying the CDC criteria
also lie buried in the literature. Three diseases, progressive multifocal
leukoencephalopathy (PML), disseminated cryptococcosis and disseminated
CMV infection will sene to illustrate a phenomenon true of all the opportunistic
diseases associated with AIDS.
Among the diseases indicative of AIDS in an otherwise healthy induvidual
with no known cause of immunosuppression is PML (CDC, 1987). PML was first
described in 1958 (Astrom et al., 1958). By 1970, some 50 cases
of PML had been described (Fermaglich et al., 1970), of which five
were previously healthy individuals (Astrom et al., 1958; Smith,
1959; Richardson, I961; Silverman and Rubinstein, 1965; Fermaglich et
al., 1970), and two others were indìviduals whose predisposing
diseases - hypersplenism (Weinstein et al., 1963) and tuberculosis
(Hadington and Umiker, 1962) - are not usually associated with immune suppression.
All 7 of these previously healthy cases were male. By 1976, about 50 more
cases of PML had been reported (Matthews et al., 1976), of which
at least 5 (Bolton and Rozdilsky, 1971; Weiner et al., 1972; Faris
and Martinez, 1972; Knight et al.,1976; Rockwell et al.,
1976) and possibly one more (Matthews et al., 1976) were AIDS-like,
characterized by deficiencies in cellular immunity due to unknown causes.
In one case, even cellular immunosuppression could not be demonstrated
(Rockwell et al., 1976), which is a phenomenon that also typifies
long-term survivors among HIV-negative homosexuals with KS (Friedman-Kein
et al., 1990).
These data suggest that about 10 % of all PML cases would have qualified
as AIDS cases prior to 1981. Unfortunately, no data appear to exist on
he incidence of PML prior to this decade, so the number of possible AIDS-like
cases cannot be determined. Interestingly, the incidence of PML does not
appear to have increased with the recognition of AIDS. Between 1980 and
the end of 1984 only 4 cases of AIDS-associated PML were reported (Moskowitz
et al., 1984) - one per year on average - which is the same incidence
as in the previous 15 years.
Extrapulmonary or disseminated cryptococcosis is another disease indicative
of AIDS. Cryptococci were first isolated about a century ago, and the first
patient to be identified with a disseminated form of the disease was diagnosed
in 1894 (reviewed in Fitzpatrick and Poser, 1960). The first clinical case
of cryptococcal meningitis was described in 1914 (Verse, 1914), and thereafter
cryptococcal infections were found in virtually every organ in the body.
Some of these cases are quite interesting in the retrospective light of
AIDS: an 18-year-old male with prostatism caused by cryptococcus infection
(Tillotson and Lerner, 1965); dozens of cases of cryptococcal hepatitis
(e.g., Proknow et al., 1965; Sabesin et al., 1963);
and a very large proportion of cryptococcal meningitis cases in which no
predisposing disease was present. By 1955, some 300 cases of cryptococcal
meningitis, mainly among men (ca. 80 %), had been reported in the medical
literature (Rubin and Fucolovw, 1958). Published cases represent a small
fraction of actual cases, however, since 151 fatal cases were reported
to the National Office of Vital Statistics (United States) between 1949
and 1953 alone (Fitzpatrick and Poser, 1960). Approximately 80 % of these
patients had central nervous system complications, and 10 % disseminated
lesions involving skin and bone (Fitzpatrick and Poser, 1960). Between
a quarter and a half of all patients with cryptococcal infections through
the 1970s were also without underlying disease yet suffered from measurable
defects in cell-mediated immunity (Diamond and Bennett, 1973; Graybill
and Alford, 1974; Schimpf and Bennett, 1975; Butler et a1., 1964;
Spickard et al., 1963; Diamond and Bennett, 1974). The number of
disseminated cryptococcal infections in the absence of underlying disease
or immunosuppressive treatment can only be approximated. Voluntary reporting
attributed 788 deaths to cryptococcal meningitis between 1952 and 1963
in the US, or 66 per year (CDC, 1965). Cryptococcal meningitis cases, however,
represent only about half of all disseminated cryptococcal infections (Duperval
et al., 1977), so that the total number of disseminated cryptococcosis
cases probably exceeded 120 per year during this period. If a quarter of
these cases had no predisposing disease (see above), then it is probable
that about 30 of these cases would have qualified as AIDS cases each year
until 1963. All published reports agree that the incidence of cryptococcosis
then increased at least ten-fold during the 1960s and '70s (Littman and
Walter, 1968; Duperval et al.,1977), which would have created a
large, apparently unrecognized base-line of well over 100 disseminated
cases per year in otherwise healthy individuals prior to the recognition
of AIDS. Notably, the geographical incidence of disseminated cryptococcal
cases paralleled the subsequent geographical incidence of AIDS, centreing
in New York City (Littman and Walter, 1968).
Several factors may have prevented the widespread recognition of these
cases. Disseminated cryptococcosis presents significant diagnostic difficulties.
In 1980, Bernad et al. (1980) reported that the classical India
ink preparation method for identifying cryptococci was only 50 % accurate
at most, and that even serological methods were far from optimal. Thus,
they found six cases of cryptococcal meningitis (and one of herpes simplex
encephalitis) that had been misdiagnosed at Massachusetts General Hospital
between 1971 and I979. Notably, 3 of these patients, including the herpes
simplex case, were men aged 20, 30 and 56 years old who presented without
an associated medical condition and without prior immunosuppressive treatment.
Each of these cases satisfies CDC requirements for a diagnosis of AIDS.
Similar tricky diagnostic problems spot the literature on cryptococcus
including notable cases such as a young Frenchman with KS that was initially
misdiagnosed as splenolymphatic lymphoma; his case was complicated by toxoplasmosis
and a terminal crytpococcal infection that was diagnosed only at autopsy
(Mongin et al., 979). Such cases suggest that many AIDS cases were
similarly misdiagnosed or never diagnosed prior to 1981, and that part
of the "epidemic" of the past decade has resulted from better
diagnostic techniques, identification of risk groups, and increased awareness
among physicians themselves of the opportunistic infections associated
with AIDS. We tend to forget that knowledge, like disease, can also spread
in an epidemic fashion and that the identification of any disease is always
accompanied by an exponential increase in diagnoses, whether the disease
is new or not. This statement can be verified simply by analysing the rate
at which reports of cryptococcosis, Pneumocystis pneumonia, or KS,
for instance, appear following their initial identification.
A similar history characterizes disseminated CMV infections. According
to the CDC, CMV disease of an organ other than the liver, spleen, or lymph
nodes in a patient greater than one month of age is diagnostic of AIDS
(CDC, 1987). Cases of CMV matching these requirements exist in the medical
literature since the disease was first identified in adults.
The first adult case of CMV was identified in a 36-year-old male by
von Glahn and Pappenheimer in 1925. The patient had CMV inclusion bodies
in the lungs, liver and colon; had no evidence of cancer; and had not been
treated with antibiotics, chemotherapy, steroids, or blood transfusions
(von Glahn and Pappenheimer, 1925). Between 1925 and 1962, 40 more cases
of CMV were identified in adults, of which 15 fit the surveillance definition
of AIDS (reviewed in Wong and Warner, table 1). Wong and Warner reported
another 14 cases in 1962 from the University of Chicago Clinics and Hospitals,
of which 3 cases are AIDS-like (Wong and Warner, table 2) and 4 more cases
in 1964, of which 1 (case 1) was AIDS-like (Levine et al., 1964).
Klemola et al. (1972) recognized 18 cases of CMV mononucleosis between
1965 and 1968 at the Aurora Hospital in Helsinki, Finland, of which 17
were in previously healthy adults, and one in a previously healthy 1-year-old
girl who also developed CMV pneumonia. A further 14 cases in previously
healthy adults occurred at the same hospital from 1969-1971, of which 2
developed CMV pneumonia (Klemola et al., 1972). In 1967, physicians
at the same hospital established adult CMV disease as a cause of neuropathies
- a frequent problem for AIDS patients - which led to the recognition of
a large number of such cases in the succeeding decade (Ho, 1982; Lindboe
et al., 1986). CMV infections have also been associated with known
risk factors for AIDS. A New York City heroin addict was found to have
acquired a CMV infection by sharing needles (Smolar et al., 1975),
and a surgical patient developed a fatal, disseminated CMV infection following
massive blood transfusion (Brownig et al., 1980).
Altogether, no less than 1 in 10 cases of adult CMV, and perhaps as
high as 3 in 10, may have qualified as AIDS cases prior to 1979. Since
the vast majority of cases of adult CMV infections were diagnosed at a
handful of hospitals where CMV specialists resided, it is probable that
the actual incidence of cases is far greater than existing reports indicate.
A Mayo Clinic autopsy study performed in 1975 found that 44 of 502 (8.8
%) unselected autopsies yielded CMV isolates from lungs, pleural and bronchial
tissues, and kidney. The majority of patients had been treated for various
cancers and renal allograft rejection, but 13 of 296 patients (4.4 %) who
had died of cardiovascular, cerebrovascular and pulmonary diseases also
developed disseminated CMV infections (Smith et al.,1975). These
data suggest that CMV infections were far more common than generally thought
but were neither diagnosed pre- nor postmortem at the vast majority of
hospitals. Although I have not reviewed the literature on childhood CMV
infection here, the same general figures appear to apply to the incidence
of AIDS-like infections in infants over the age of 1 month (reviewed in
Kinney, 1942; Medearis, 1957).
It is important to note that, like KS, disseminated cryptococcosis,
PML and disseminated CMV infections, my preliminary reviews of other AIDS-related
opportunistic infections such as Pneumocystis pneumonia, chronic
and oeosophageal candidiasis, disseminated tuberculosis and atypical mycobacterial
infections, all show the same pattern of AIDS-like cases reported for as
long as the disease has been described in the medical literature with increasing
numbers of such cases during the two decades prior to 1980. It is also
interesting to note that medical reports of almost all the opportunistic
diseases associated with AIDS grow at an exponential rate from the time
of their first observation until the recognition of AIDS. This observation
suggests either that the rate of all opportunistic infections is increasing
as quickly as AIDS itself ; that as we conquer other infectious diseases,
opportunistic diseases become a more common problem; and/or that our diagnostic
ability has increased continuously. Whatever the cause of this phenomenon,
we must consider the possibility that at least part of the recognition
of AIDS resulted from factors other than the emergence of a new disease
agent. Certainly, a quite significant proportion of AIDS-like cases existed
prior to the recognition of AIDS, and probably continue to contribute significantly
to the current epidemic. This baseline of pre-existing AIDS-like cases
must be taken into account in any future epidemiological study of AIDS,
and cer-tainly makes all previous studies unreliable since all have assumed
that AIDS did not exist as a significant problem prior to 1979.
The recognition of a significant number of pre-1979 AIDS-like cases
creates other problems for our current understanding of AIDS. If HIV is
a new and necessary cause of AIDS as most AIDS researchers argue, then
there must be some other cause of these pre-1979 AIDS-like cases. If non-HIV
im-munosuppressive agents are sufficient to cause AIDS, then there is no
reason to think that these agents are not at work during the present epidemic
just as they were in the past. On the other hand, HIV may not be a new
disease agent. Increasing numbers of reports maintain that both HIV-I and
HIV-2 were present in Western Europe and the Americas in the 1950s and
'60s (Elvin-Lewis et al., 1973; Witte et al., 1984; Garry
et al.,1988; Froland et al.,1988; Nahmias et al.,1986;
Dufoort et al., 1988; Corbitt et al.,1990). But if HIV is
not new, then why has AIDS emerged as a major medical problem only in the
last decade? In either case, significant rethinking of AIDS aetiology and
epidemiology is required. Either the transmission of endemic HIV, non-HIV
immunosuppressive agents, or some combination of these with HIV, increased
dramatically in the past two decades. And, indeed, huge increases in the
incidence of multiple immunosuppressive risk factors associated with groups
at high risk for AIDS are documentable.
Homosexual and bisexual men are at the highest risk of developing AIDS
(CDC, 1989). Although no direct measure of homosexual activity exists for
any period in history, indirect measures universally indicate recent and
significant increases in both the frequency of sexual encounters among
"gay" men and in specific forms of sex associated either directly
or indirectly with immunosuppression. For example, Kinsey et al.
reported in 1948 that most of the homosexual men they interviewed had gone
for months or even years between sexual encounters (Kinsey et al.,1948).
"Gay liberation" during the 1970s, however, was often accompanied
by sexual liberation and promiscuity so that by 1980 many gay men were
having sexual relations with several partners each week (Dritz, 1980).
It is typical of homosexual AIDS patients to have had hundreds or thousands
of sexual partners during the course of only a few years.
Promiscuity and unusual sexual practices led to measurable changes in
the types and numbers of sexually transmitted diseases recorded by health
officials. Studies of the prevelance of syphilis around 1960 demonstrated
that in Los Angeles and Vancouver at least 70 % of cases among men were
associated with male homo- or bisexual activity (Larson, 1959; Tarr and
Lugar, 1960). When the rate of syphilis among white males in the United
States increased by 311 % between 1967 and 1979, it was found to be due
mainly to increased homosexual activity (Fichtner et al., 1983).
Cases of gonorrhoea increased from 259,000 in 1960, to 600,000 in 1970,
to over 1,000,000 in 1980 (CDC, 1981), also in a large part due to increased
homosexual activity.
The number of HBV cases also increased dramatically, from 1,500 cases
in 1966 to 8,300 in 1970 to 19,000 in 1980 and 25,000 in 1987 (CDC, 1981;
CDC, 1989b). Although some of this increase is undoubtedly due to intravenous
drug use, many AIDS patients have both homosexuality and drug abuse as
risks, and evidence suggests that the increase is mainly due to disease
spread among homosexual and bisexual men (Szmuness et al., 1975).
For example, over 60 % of 3,816 homosexual men examined in 5 US cities
had immunological or other evidence of HBV infection in 1979 (Schreeder
et al.,1982) although the rate among heterosexuals was less than
10 %. The rate of seropositivity was directly related to duration of homosexual
activity, number of non-steady sexual partners and to the practices of
receptive anal intercourse and other types of sexual activity, such as
fitsting, that caused trauma to the rectal mucosa (Szmuness et al,
1975; Schreeder et al., 1982). A similar increase in hepatitis A
during the same period was also noted among homosexual men, but in no other
part of the population (Corey and Holmes, 1980).
Practices associated with disease transmission or with increased risk
of unusual infections and complications also began to be noticed by clinicians
during the 1960s and early 1970s. Fisting was first described in the medical
literature during the 1970s as a sexual practice leading to frequent medical
sequelae, and medical experience and surveys by Sohn, et al. (1977)
strongly suggested that this practice was an essentially new and rapidly
proliferating activity exclusive to the gay community (see also Weinstein
et al., 1981). The sale of inhalation nitrites among the gay community
was also documented to have increased dramatically during the same period
(Goedert, 1984), and since one of the major uses of such drugs among gay
men is to facilitate anal intercourse and fisting (Newell et al.,
1985), it is probable that the two practices evolved together.
Newell et al. (1985) have reviewed the various sources indicating
that nitrite was virtually unknown among gay men as of 1960 and became
nearly synonymous with gay life in various cities by the mid-1970s, approaching
an estimated rate of 80 % incidence in the male homosexual community as
a whole. They also summarize relevant data concerning the social spread
of nitrite use since the non-prescription commercial availability in 1960
of amyl nitrite, its prescription limitation in 1969 followed by the commercialization
of butyl and isobutyl nitrites in 1970, and the beginning of the "popper
craze" - mainly among gay men - in the mid-1970s. Several studies
have argued that nitrite use is correlated with the incidence of KS in
gay men (Goedert, 1984; Newell et al., 1985; Jaffe et al.,
1983; Marmor et al., 1982; Haverkos et al., 1985).
Forms of masochistic and traumatic sex other than fisting, popularized
by the Eulenspiegel Society and Hellfire Clubs, also appear to have become
more popular during the last two decades (Marotta, 1981). A 1980 study
documented significantly higher rates of anal intercourse, fisting, and
oral-genital contact among homosexual men in cities such as San Francisco
and Los Angeles that have high rates of AIDS than in cities in which AIDS
is rare, such as Denver and St. Louis (Corey and Holmes, 1980).
The first medical report of proctological lesions associated with homosexual
activity came from a physician in New York City in 1964 who noted that
among 18 avowedly homosexual patients, he had observed 4 instances of anal
ulceration associated with trauma; 5 instances of granulomatous anorectal
lesions; 5 instances of non-specific anorectal lesions; and 5 cases of
perianal condyloma acuminata (Marino, 1964). He described these symptoms
as very unusual. A decade later, such symptoms were no longer surprising.
Of 260 gay men, comprising 10 % of a private proctological practice in
New York City in 1976, 134 patients had condyloma acuminata, 43 haemorrhoids,
31 non-specific proctitis, 30 anal fistulas,18 perirectal abscesses, 18
anal fissures, 17 amoebiasis,16 pruritis ani and 7 "tauma and foreign
bodies" (Kazal et al., 1976). It is now accepted that such
injuries and infections greatly increase the risk of concurrent infections
(HIV or otherwise) and of semen gaining access to the immune system following
anal intercourse.
Other diseases such as amoebiasis, shigellosis and giardiasis, that
are are now known to be associated with anal intercourse and anal-oral
contact were first observed to be sexually transmitted during the past
two decades as a result of their unusual occurance among gay men. The increasing
prevalence of these diseases among male homosexuals therefore provides
an indirect measure of the increasing frequency of sexual contacts among
the gay community during the 1970s. All of these diseases were relatively
rare in the US and England prior to the 1970s and outbreaks were almost
alyways associated with faecal contamination and poor public hygiene (Mildvan
et al., 1977). This picture changed dramatically in the aftermath
of "gay liberation".
Cases of amoebiasis reported to the CDC, for example, rose from a relatively
constant level of less than 2,500 prior to 1972 to more than 7,300 in 1982
(an increase of 320 %) (CDC, 1989b). Almost all of the new cases were among
men, most of whom were identified as gay. Schmerin and his colleagues at
The New York Hospital, for example, reported that amoebiasis was identified
in the stools of 98 patients between 1971 and 1976. All of the 42 women
for whom information existed acquired the disease from travel outside the
US or were immunodeficient. Fifty-six patients were male. Thirty of these
male patients had contracted the disease while visiting endemic areas outside
the US. No information was available for 6 male patients. The remaining
20 male patients were all homosexuals who had not travelled outside of
the New York. Metropolitan area. There were no cases of non-traveller amoebiasis
in 1971 in their sample and the number grew yearly therafter. Almost half
of these patients also had either concomitant shigellosis, giardiasis,
syphilis, gonorrhoea, and/or hepatitis or a history of these diseases (Schmerin
et al., 1977). By 1977, physicians recognized that the presence
of any enteric pathogen in a man who had not travelled out of the country
was likely to have resulted from homosexual activity (Vaisrub, 1977).
These results confirmed previous studies by Most and Kean that the Manhattan
homosexual community had begun to display the unusual disease profile typical
of "a tropical isle" or third-world country beginning about 1968
(Most, 1968; Kean, 1976). Nearly 60 % of all cases of shigellosis in the
New York metropolitan area were among gay men by 1976 (Drusin et al.,
I976) and an epidemic of the disease was noted in the gay community in
San Francisco in 1974 (Dritz and Bach, 1974). Schmerin et al. similarly
found that nearly 90 % of giardiasis cases among non-travellers living
in New York were avowvedly homosexual in 1977 (Schmerin et al.,
1977).
All of these reports are only a fraction of published and private observations
by "physicians with homosexual male patients in New York City, San
Francisco, and Boston [who] have also noted a marked increase in enteric
protozoal infections occurring in those who practice analingus" (Mildvan
et al., 1977). Much the same picture began to emerge in Great Britain
at the same time (Kacker, 1973; Meyers et al.,1977). Not surprisingly,
the recogni-tion of an epidemic of lymphadenopathy in gay men has also
been traced back into the decade prior to the recognition of AIDS, but
went unnoticed at the time (Miller et al., 1984).
These data strongly suggest that the gay liberation movement resulted
in a great increase in promiscuity among gay men as well as significant
changes in sexual practices that made rectal trauma, immunological contact
with semen, use of recreational drugs and the transmission of many viral,
amoebal, fungal and bacterial infections much more common than in the decades
prior to 1970 (Sonnabend et al., 1984; Sonnabend, 1989). Promiscuity,
engaging in receptive anal intercourse and fisting are the 3 highest risk
factors associated with AIDS among gay men (Marmor et al., 1982;
Darrow et al., 1987). Each of these risk factors is correlated with
immunosuppression (Root-Bernstein, 1990; Sonnabend et al.,1984;
Sonnabend, 1989), as are the other aspects of the gay lifestyle.
These data concerning medical problems associated with male homosexuality
therefore strongly suggest that recent changes in lifestyle played a major
role in vastly enlarging the homo- and bisexual male population at risk
for developing immunosuppression, whether it resulted from transmitting
HIV infections combined with other immunosuppressive agents, or from some
combination of the non-HIV agents alone.
Thus, I maintain that AIDS is almost undoubtedly a very old disease
among gay men, but that it is only recently, especially in Western nations,
that newly-evolved gay sexual and drug practices spawned an environment
in which the microbiological and immunological manifestations of these
activities became widespread enough to affect a significant proportion
of gay men and to be correlated with the underlying causes. We must also
recognize that the willingness of gay men to identify themselves as such
was crucial evidence in recog-nizing AIDS, evidence that was not available
prior to gay liberation.
Intravenous drug abuse is also recognized as conferring a high risk
of AIDS (CDC, 1989). Unfortunately; data on i.v. drug use seems to be nearly
as difficult to obtain as that on homosexual behaviour. However, virtually
all measures of opiate-related drug abuse indicate an escalating problem
during the past three decades. In England, the number of registered heroin
addicts rose from 10 in 1960 to 509 in 1966 (Bewley et al., 1968)
and grew exponentially thereafter. Similarly, the Bureau of Narcotics of
the United States Government reported that the total number of registered
heroin addicts increased from 45,000 in 1960 to 68,000 in 1970 to 99,000
in 1973 (an increase of 120 %) (Golenpaul, 1975). Estimates of the actual
number of addicts in the US in 1973 were between 300,000 and 500,000 (Golenpaul,
1975). About half of these addicts were to be found in New York City; other
urban centres associated with AIDS, such as Los Angeles and San Francisco,
were also among the cities reporting the most addicts (Hansen, 1964-1979)
.
The number of arrests for breaking narcotic drug laws shows an even
larger increase than that among registered drug addicts : 29,000 arrests
in 1962; 100,000 in 1967; 190,000 in 1969; 400,000 in 1971; and 530,000
in 1977 (Hansen,1964-1979). The breakdown of figures by sex and race roughly
mirrors AIDS risk among i.v. drug abusers: 6 times as many men as women
were arrested for breaking narcotics laws; and almost equal numbers of
whites and minorities.
A similar epidemic of i.v. drug abuse is also evident from the federal
government's Drug Abuse Warning Network (DAWN). DAWN data indicates that
in virtually every major city in the US, heroin overdoses seen at hospital
emergency rooms quadrupled between 1976 and 1985 (USDHHS,1985). The use
of cocaine, which may also be taken intravenously, increased nearly a 1,000
% in all major cities (USDHHS, 1985), and serum hepatitis cases, an indirect
measure of i.v. drug abuse, tripled during the same period (CDC, 1981;
CDC, 1989b). The medical literature also reflects these trends with a spate
of arti-cles beginning in the late 1960s concerning the epidemic of heroin
addiction that physicians began to encounter on a regular basis (e.g. Bewley
et al., 1968; Dole, 1973).
Again, as is the case with gay men, the medical literature reflects
the growing problem of drug abuse with the recognition of unusual immunologic
and infectious complications in abusers. The high mortality and vastly
decreased longevity of opiate addicts was studied (Bewley et al.,
1968; Louria et al., 1967; Cherubin, 1967). Severe systemic infections
with Gram-negative bacteria, Candida and other opportunistic organisms
began to be reported (Hussey and Katz, 1950; Briggs et al., 1966;
1967; Cherubin, 1967 ; Cherubin and Brown, 1968; Louria et al.,
1967).
Disseminated tuberculosis (another diagnostic indicator of AIDS) was
identified as a major complication of drug addiction in 1973 (Firooznia
et al., 1973) at the same time that lymphadenopathy was recognized
as a common and often misdiagnosed problem in drug abusers (Sapira, 1968;
Geller, 1973; Miller et al., 1984), and concomitant immunological
dysfunction was identified in such patients (Brown, 1974). Malnutrition
was recognized as an immunosuppressive risk associated with intravenous
i.v. drug abuse by 1976 (Gambara and Clarke, 1976; Aylett, 1978; Nakah
et al , 1979). The inversion of T-cell subsets accompanying opiate
use had been identified by 1980 (McDonough et al., 1980).
These data provide a strong basis for concluding that acquired immunodeficiencies
are not new among those groups at highest risk for AIDS; that non-HIV immunosuppressive
agents play a significant role in debilitating individuals in these high-risk
groups; and that behaviour associated with the spread of these non-HIV
immunosuppressive factors proliferated at an alarming rate prior to and
concomitant with the recognition of AIDS. A number of important questions
are raised by these facts.
First, what is the role of HIV in AIDS? Current data do not permit an
unambiguous answer to this question. HIV may be a necessary cause of AIDS,
but the number and potency of non-HIV immunosuppressive agents may determine
the rate at which AIDS develops. HIV may be a frequent but unnecessary
agent that contributes to the immunosuppression that characterizes AIDS,
but HIV may not be capable of initiating or causing AIDS on its own. Or
HIV may simply be a common opportunistic organism, like so many others
associated with AIDS, that serves as a highly selective marker for significant
prior immune deficiency having other causes (Rubin, 1988). Each of these
possibilities leads to very different and quite novel reinterpretations
of AIDS aetiology and epidemiology.
If HIV is a necessary cause of AIDS, and a significant number of AIDS-like
cases predate 1979 by a century or more, then HIV must be a far older infection
than is generally recognized. If so, then HIV has been endemic in Western
Europe and the Americas for some time, a point argued recently by Duesberg
(in press) based upon a review of various epidemiological data.
There is, of course, no direct evidence for HIV infection in most AIDS-like
cases prior to 1979, and for obvious reasons, there is not likely to be.
Lack of evidence should not, hoywever, be interpreted as meaning that the
opposite is true (i.e. that HIV must be new), but simply that some types
of data are not, for historical reasons, available to us. The few documented
cases of HIV infections prior to 1979 become all the more important in
consequence. Assuming then that HIV is indeed an old infection, it follows
that the sudden growth of AIDS cases during the past decade must be due
to a combination of new forms of transmission of HIV, rather than
the newness of HIV itself. The data reviewed here concerning changes in
gay sexual and recreational drug habits and the separate but concurrent
epidemic of i.v. drug abuse certainly demonstrates that unusual forms of
transmission did grow tremendously in tandem with the recognition of AIDS.
To what extent advances in diagnosis, definition of risk groups and dissemination
of this information to physicians added to the numbers of patients recognized
must, unfortunately, remain in the realms of conjecture.
The difficulty in maintaining that HIV is a necessary cause of AIDS
is that the same modes of transmission that may have disseminated HIV -
anal intercourse, fisting, i.v. drug abuse and contact with blood and blood
factors - are known to be immunosuppressive in themselves and can also
transmit other immunosuppressive agents such as CMV and HBV. Thus, it is
impossible to maintain that any individual in a high-risk AIDS group was
infected only by HIV and had no other immunosuppressive factors at work
concurrently.
Indeed, in light of the fact that after more than a decade, AIDS continues
to be associated almost completely with high-risk groups (CDC, 1990), it
is highly improbable that AIDS is caused by a single, transmissible agent,
and highly probable that non-HIV immunosuppressive factors act either synergistically
with each other or with HIV to cause AIDS. I therefore predict that AIDS
will have a signifiicant impact only on groups of people who have identifiable
causes of immune suppression other than HIV. Among non-i.v.-drug-abusing
heterosexuals contracting AIDS, it will therefore be necessary to study
whether other risk factors such as anal intercourse, recreational drug
abuse, malnutrition, anorexia and related factors are significant in the
development of the disease.
The most important implication of a synergistic aetiology for AIDS is
that contracting an HIV infection is not, in and of itself, predictive
of developing AIDS. To some extent, this conclusion is already recognized:
it is well established that AIDS may develop within months of an HIV infection
in some patients while others are healthy decades later (Peterman et
al., 1988; Dufoort et al., 1988). This wide variability can
easily be explained either if HIV requires cofactors for its activation,
or if HIV is itself opportunistic and is therefore active only in previously
or concurrently immunosuppressed individuals. Certainly HIV is very difficult
to transmit compared with other viruses such as HBV or EBV, and this fact
argues strongly in favour of the necessity of cofactors. This fact may
also explain why only individuals who have multi-ple non-HIV causes of
immunosuppression actively express the retrovirus following infection.
If these observations are admitted, however, it must be further admitted
that HIV may not be a necessary cause of acquired immune deficiency, but
may act only to exacerbate or opportunistically mark a preexisting deficiency.
Now, whatever form the synergistic theory of AIDS aetiology takes, it
necessitates a re-evaluation of whether AIDS is transmissible. The current
dogma is that AIDS is transmissible because HIV is a sufficient cause of
the syndrome. Duesberg, on the other hand, argues that AIDS is not transmissible
because HIV is irrelevant to the understanding of AIDS. AIDS, he claims,
is due to drug abuse and gay male sexual practices. But when the full range
of non-HIV immunosuppressive factors are included in the aetiology of AIDS,
neither extreme seems tenable. HIV itself is, of course, transmissible,
as are other immunosuppressive factors associated with AIDS, such as CMV,
EBV , HBV, mycoplasmas, the sexually transmitted diseases and the infections
associated with the "gay bowel syndrome". We do not know whether
a sufficient combination of these factors can act synergistically to cause
AIDS. They may, and research is needed to confirm this hypothesis.
If they can cause AIDS, either in the presence or absence of HIV, then
AIDS could be transmissible. But many non-HIV immunosuppressive factors
are not transmissible: blood transfusions, blood-derived factor exposure,
i.v. and recreational drug use, malnutrition and semen-induced autoimmunity,
for example. Again, we do not know whether combinations of these agents
in and of themselves or in combination with HIV are sufficient to cause
AIDS. If they are, then AIDS is not, in the strictest sense of the word,
transmissible.
In short, the multifactorial, synergistic aetiology of AIDS that I am
proposing here predicts that there are many ways of acquiring secondary
immunodeficiencies, and that all of these may be manifested in what we
now call AIDS. Clearly, if we are to be able to predict who is going to
get AIDS, if we are to devise public health policies to control AIDS, and
if we are to devise strategies to prevent or cure AIDS, it is imperative
that we find out whether HIV is necessary to cause AIDS or whether non-HIV
immunosuppressive agents are sufficient. Even if only 5 % of AIDS patients
are truly HIV-negative, as current data suggest, and even if we decide
to recategorize these patients as suffering from some form of acquired
immunosuppression other than AIDS (as some investigators are now urging)
the fact remains that these people develop many or all of the same symptoms
as AIDS patients, and it is just as important to discover the cause or
causes of their problems as it is of those who have an HIV infection. What
we cannot afford - in terms of human lives or misdirected research - is
to ignore the exceptions to the HIV dogma. These exceptions tell us that
we do not yet grasp the whole story of AIDS. We must be willing to research
and rethink.
Many things must be researched and rethought in light of the role of
non-HIV factors in AIDS. Epidemiological predictions based on AIDS being
a new disease must be recalculated to account for a significant baseline
of AIDS cases and HIV infections prior to 1979. Accounting for these factors
may very well explain why the number of AIDS cases have not grown at nearly
the rate predicted by early models of the syndrome. Certainly, models predicting
the transmission of AIDS by a single infectious agent must be reworked
to account for both infectious and non-infectious immunosuppressive cofactors.
Treatments for AIDS must expand to include not only anti-retrovirus therapies,
but therapies for all of the non-HIV factors as well (Papadopulos-Eleopulus,
1988). Indeed, we must recognize that anti-retrovirus therapies, some of
which are themselves immunosuppressive, may actually harm patients rather
than help them, particularly if HIV is itself opportunistic rather than
causative, or if the patient is HIV-negative. Public health policies must
expand to address the modes of transmission of both HIV and non-HIV immunosuppressive
factors, the factors that are not transmissible and the behaviour patterns
(whether sexual, drug-related, nutritional, or medical) that are associated
with the epidemic growth of immunosuppressive factors in high-risk groups.
If the multifactorial synergistic theory of AIDS summarized here is correct,
we will not control AIDS until this rethinking and reacting is accomplished.
To summarize, I neither believe, as do Gallo and his colleagues, that
HIV is sufficient to explain AIDS, nor do I accept Duesberg's claim that
HIV is totally irrelevant to understanding AIDS, (Duesberg,1988; 1989;
1990). HIV clearly plays some role in AIDS; but so do other infectious
agents such as CMV, EBV, HBV and mycoplasmas that are equally prevalent
among AIDS patients; and so do non-transmissible and profoundly immunosuppressive
agents such as semen, blood, drugs and malnutrition.
One final point is also worth consideration. The recognition that non-HIV
immunosuppressive factors play a causative role in AIDS, far from undermining
current public health attempts to control AIDS through "safe sex"
and control of drug use, suggests that current HIV-based measures are not
working because they are too narrow.
For example, providing clean needles to addicts does not obviate the
immunosuppressive effects of opiate abuse, its frequent concomitant malnutrition,
or the prostitution which is often used to pay for the illicit drugs. Gay
men need to know that even "safe sex" measures will not protect
them from the immunosuppressive effects of recreational drugs, antibiotic
abuse, rectal damage following anal intercourse, fisting and anal masturbation,
malnutrition following gay bowel syndrome, or from infections contracted
by anal-oral contact.
Heterosexuals need to realize that a combination of recreational drug
abuse, poor eating habits, bulimia or anorexia, and promiscuous anal intercourse
(Lorian, 1988) can be profoundly immunosuppressive, whether they become
infected with HIV or not.
Physicians also need to become more aware of the immunosuppressive risks
of some of the common procedures they use such as blood transfusions, factor
therapies and long-term antibiotic use.
Acquired immunosuppression is, in short, a much more multifarious and
complicated affair than the current views of AIDS admit and our research
and public policies must be altered to recognize this fact.
AIDS = acquired immune deficiency syndrome.
HIV = human immunodeficiency v.irus.
CMV = cytomegalovirus.
KS = Kaposi's sarcoma.
EBV = Epstein-Barr virus.
PML = progressive multifocal leukorocephalopathy.
HBV = hepatitis B virus.
HCV = hepatitis C virus.
REFERENCES
AFRASIABI, R., MITSUYA SU, R.T., NISHANIAN, P., SCHWARTZ,
K. & FAHEY J.L. (1986), Characterization of a distinct subgroup of
high-risk persons vv.ith Kaposi's sarcoma and good prognosis who present
with normal T4 cell num-ber and T4: T8 ratio and negative HTLV-III/LAV
serologic test results. Amer. J. Med., 81, 969-973.
ASTROM, K.-E., MANCALL, E.L. RICHEARDSON, E.P. Jr. (I958),
Progressive multifocal leuko-encephalopathy. Brain, 81, 93.
AYLETT, A. (1978), Some aspects of nutritional state in
"hard" drug addicts. Brit. J. Addiction, 73, 77-81.
BECK, J.S., et al. (1985), T4 lymphopenia in patients
with active pulmonary tuberculosis. Clin. exp. Immunol., 60, 49.
BEDDALL, A.C., et al. (1985), Lymphocyte subset
ratios and factor VIII usage in hemophilia. Arch. Dis. Child., 60,
530.
BERNAD, P.G., SZYFELBEIN, W.M., WEISS, H.D. & RICHARDSON,
E.P. (1980), Diagnosis of cryptococcal meningitis by cytological methods:
an old technique revisited. Neurology, 30, 102-105.
BEWLEY, T.H., BEN-ARlE, O. & JAMEs, I.P. (1968), Morbidity
and mortality from heroin dependence. 1. - Survey of addicts known to Home
Office. Brit. Med. J., l, 725-732.
BOLTON, C.F. & ROZDILSKY, B. (1971), Primary progressive
multifocal leukoencephalopathy: a case report. Neurology, 21, 72-77.
BRAMBILLA, G. (1985), Genotoxic effects of drug/nitrite
interaction products : evidence for the need of risk assessment. Pharmacol.
Res. Commun., 17, 307-321.
BRIGGS, J.H., MCKERRON, C.G., SOUHAMI, R.L., TAYLOR, D.J.E.
& ANDREWS, H. (1967), Severe systemic infections complicating "mainline"
heroirt addiction. Lancet, II, 1227-1231.
BRIGGS, J.H., MCKERRON, C.G., SOUHAMI, R.L., TAYLOR, D.J.E.
& ANDREWS, H.J. (1966), Severe pneumonia in heroin addicts. Lancet,
II, 964.
BROWN, S.M., STIMMEL, B., TAUB, R.N., KOCHWA, S. &
ROSENFIELD, R.E. (1974), Immunologic dysfunction in heroin addicts. Arch.
Intern. Med., 134, 1001-1006.
BROWING, J.D., MORE, I. & BOYD, J.F. (1980), Adult
pulmonary cytomegalic inclusion disease: report of a case. J. Clin.
Path., 33, 11-18.
BURKE, D.S., BRUNDAGE, J.F., GOLDENBAUM, M., GARDNER,
I., PETERSON, M ., VISINTINE, R., REDFILED, R. & the Walter Reed Retrovlrus
Research Group. (1990), Human immunodeficiency virus infections in teenagers.
J. Amer. med. Ass., 263, 2074-2077.
BUTLER, W.T., ALLING, D.W., SPICKARD, A., et al.
(1964), Diagnostic and prognostic value of clinical and laboratory findings
in crytpococcal meningitis: a follow-up study of forty patients. New
Engl. J. Med., 270, 59-67.
CARNEY, W.P., RUBIN, R.H., HOFFMAN, R.A., HANSEN, W.P.,
HEALY, K. & HIRSCH, M.S. (1981), Analysis of T lymphocyte subsets in
cytomegalovirus mononucleosis. J. Immunol., 126, 2114-2116.
Centers for Disease Control (1965), Annual Supplement.
Mortal. Morbid. Weekly Rep., 13, passim.
Centers for Disease Control (1981), Annual Summary,1980.
Mortal. Morbid. Weekly Rep., 29, passim.
Centers for Disease Control (1987), Revision of the CDC
surveillance case definition for acquired immunodeficiency syndrome. J.
Amer. med. Ass., 256, 1143-1154.
Centers for Disease Control (1989), Summary of notifiable
diseases, United States, 1988. Mortal. Morbid. Weekly Rep., 37,
passim.
Centers for Disease Control (1989), Update: acquired immunodeficiency
syndrome - United States, 1981-1988. Mortal. Morbid. Weekly Rep.,
38, 229-236.
CHANDRA, R.K. (1983), Malnutrition, in "Primary
and secondary immunodeficiency disorders" (R.K. Chandra), (pp. 187-203).
Churchill Livingstone, Edinburgh.
CHANDRA, R.K., GUPTA, S. & SINGH, H. (1982), Inducer
and suppressor T-cell subsets in protein-energy malnutrition: analysis
by monodonal antibodies. Nutr. Res., 2, 21-26.
CHERUBIN, C.E. (1967), The medical sequelae of marcotic
addiction. Ann. lntern. Med. 67, 23-33.
CHERUBIN, C.E. & BROWN, J. (1968), Systemic infections
in heroin addicts. Lancet, I, 298-299.
CORBITT, G., BAILEY, A.S. & WILLIAMS, G. (1990), HIV
infection in Manchester, 1959. Lancet, II, 51.
COREY, L. & HOLMES, K.K. (1980), Sexual transmission
of hepatitis A in homosexual men: incidence and mechanism. New. Engl.
J. Med., 302, 436-438.
DARROW, W.W., ECHENBERG, D.F., JAFFE, H.W., et al. (1987),
Risk factors for human immunodeficiency virus (HIV) infections fn homosexual
men. Amer. J. publ. Hlth, 77, 479-483.
DAUS, H., SCHWARZE, G. & RADTKE, H. (1989), Reduced
CD4+ count, infections and immune thrombocytopenia without HIV infection.
Lancet, Il, 559-S60.
DIAMOND, R.D. & BENNETT, J.E. (1973), Disseminated
cryptococcosis in man: decreased lymphocyte transformation in response
to Cryptococcus neoformans. J. infect. Dis., 127, 694-697.
DIAMOND, R.D. & BENNETT, J.E. (1974), Prognostic factors
in cryptococcal meningitis. Ann. Intern. Med., 80, 176-181.
DOLE, V.P. (1973), Heroin addiction - an epidemic disease.
The Harvey Lectures, 1971-1972. (pp. 199-214). Academic Press, New York,
London.
DONOHOE, R.M., NICHOLSON, J.K., MADDEN, J.J., et al.
(1986), Coordinate and independent effects of heroin, cocaine, and alcohol
abuse on T-cell E-rosette formation and antigenic marker expression. Clin.
Immunol. Immunopathol., 41, 254-264.
DONOHOE, R.M., BUESO-RAMOS, C., DONOHOE, F., et al.
(1987), Mechanistic implications of the findings that opiates and other
drugs of abuse moderate T-cell surface receptors and antigenic markers.
Ann. N. Y. Acad. Sci., 496, 711-721.
DOWD, P.S. & HEATLEY, R.V. (1984), The influence of
undernutrition on immunity. Clin. Sci. 66, 241-248.
DRITZ, S.K. & BACH, A.F. (1974), Shigella enteritis
venerially transmitted. New Engl. J. Med., 291, 1194.
DRITZ, S.K. (1980), Medical aspects of homosexuality.
New Engl. J. Med., 302, 463-464.
DRUSIN, L.M., GENVERT, G. & TOPF-OLSTEIN, B. (1976),
Shigellosfs: another sexually transmitted disease. Brit. J. Vener. Dis.,
52, 348-350.
DUESBERG, P.H. (1988), HIV is not the cause of AIDS. Science,
241, 514-517.
DUESBERG, P.H. (1989), Human immunodeficiency virus and
acquired immunodeficiency syndrome: correlation but not causation. Proc.
nat. Acad. Sci. (Wash.), 86, 755-764.
DUESBERG, P.H. (1990), AIDS: non-infectious deficiencies
acquired by drug consumption and other risk factors. Res. Immunol.,
141, 5-11.
DUFOORT, G., COUROUCE, A.-M., ANCELLE-PARK, R. & BLETRY,
O. (1988), No clinical signs 14 years after HIV-2 transmission via blood
transfusion. Larcet, II, 510.
DUPERVAL, R., HERMANS, P.E., BREMMIER, N.S. & ROBERTS,
G.D. (1977), Cryptococicosis, with emphasis on the significance of isolation
of Cryptococcus neoformnans from the respiratory tract. Chest,
72, 13-19.
ELVIN-LEWIS, M., WITTE, M., WITTE, C., et al. (1973),
Systemic chlamydial infection associated with generalized lymphedema and
lymphangiosarcoma. Lymphology 6, 113-121.
FARIS, A.A. & MARTINEZ, A.J. (1972), Primary progressive
multifocal leukoencephalopathy: a central nersous system dtsease caused
by a slow virus. Arch. Neurol., 27, 357-360.
FERMAGLICH, J., HARDMAN, J.M. & EARLE, K.M. (1970),
Spontaneous progressive multifocal leukoencephalopathy. Neurology,
20, 479-484.
FICHTNER, R.R., ARAL, S.O., BLOUNT, J.H., et al.
(1983), Syphilis in the United States 1967-79. Sex. Trans. Dis.,
10, 77-80.
FlROOZNIA, H., SELIGER, G., ABRAMS R.M., VALENSl, V. &
SHAMOUN, J. (1973), Disseminated extrapulmonary tuberculosis in association
with heroin addiction. Radiology, 109, 291-296.
FISCHER, E., LENHARD, V., SEIFERT, P., et al. (1980),
Blood transfusion-induced suppression of cellular immunity in man. Hum.
Immunol., 3, 187-194.
FITZPATRICK, M.J. & POSER, C.M. (1960), The management
of cryptococcal meningitis. Arch. Intern. Med., 106, 151-261; 164-274.
FREIDMAN-KEIN, A.E., SALTZMAN, B.R., CAO, Y., et al.
(1990), Kaposi's sarcoma in HIV-negative homosexual men. Lancet,
l, 168-169.
FROLAND, S.S., JENUM, P., LINDBOE, C.F., WEERING, K.W.,
et al. (1988), HIV-1 infection in Norwegian family before 1970.
Lancet, I, 1344-1345.
GAMBARA, S.E. & CLARKE, J.K. (1976), Comments on dietary
intake of drug-dependent persons. J. Amer. Diet. Assoc., 68, 155-157.
GARRY, R.F., WITTE, M.H., GOTTLIEB, A.A., et al. (1988),
Documentation of an AIDS virus infection in the United States in 1968.
J. Amer. med. Ass., 260, 2085-2087.
GATENBY, P.A. (1989), Reduced CD4+ T cells and candidiasis
in absence of HIV infection. Lancet, I, 1027.
GELLER, S.A. 8c STIMMEL, B. (1973), Diagnostic confusion
from lymphatic lesions in heroin addicts. Ann. Intern. Med., 78,
703.
GIOVANNINI, M., TAGGER, A., RIBERO, M.L., ZUCCOTTl, G.,
et al. (1990), Maternal-infant transmission of hepatitis C virus
and HIV tnfections : a possible interaction. Lancet, I, 1166.
GOEDERT, J.J., KESSLER, C.M., ALEDORT, L.M., et al.
(1989), A prospective study of human immunodeficiency virus type 1 infection
and the development of AIDS in subjects with hemophilia. New Engl. J.
Med., 321, 1141-1148.
GOLENPAUL, A. (1975), Information Please Almanac, New
York, p. 732.
GRAYBILL, J.R. & ALFORD, R.H. (1974), Cell-mediated
immunity in cryptococcosis. Cell. Immunol., 14, 12-21.
HAMILTON, J.R., OVERALL, J.C. & GLASCOW, L.A. (1976),
Synergistic effect on mortality in mice with murine cytomegalovirus and
Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albricans infections.
Infect. Immun.,14, 982-989.
HARTUNG, W.A., GOURLEY, W.K. & ARVANITAKIS, C. (1979),
Glardlasis: Cinical spectrum and functional-structural abnormalities of
the small intestinal mucosa. Gastroenterology, 77, 61-69.
HANSEN, H. (1964-1979), The World Almanac and Book of
Facts, New York, New York World Telegram.
HAVERKOS, H.W., PINSKY, P.F., DROTMAN, D.P. & BREGMAN,
D.J. (1985), Disease manifestation among homosexual men with acquired immunodeficiency
syndrome: a possible role of nitrites in Kaposi's sarcoma. Sex. Trans.
Dis., 12, 203-208.
HEADINGTON, J.T. & UMIKER, W.O. (1962), Progressive
multifocal leukoencephalopathy: case report. Neurology, 12, 434.
HO, M. (1982), Cytomegalovirus (pp. 162-164). Plenum Medical
Book Co., New York, London.
HOLE, A. 8c DAKKE, O. (1984), T lymphocytes and the subpopulation
of T helper and T suppressor cells measured by monoclonal antibodies (T
11, T4 and T8) in relation to surgery under epidural and general anaesthesia.
Acra Anaesthesiol. Scand., 28, 296.
HUMINER, D., ROSENFELD, J.B. & PITLIK, S.D. (1987),
AIDS in the pre-AIDS era. Rev. infect. Dis., 9, 1102-1108.
HUMINER, D. & PITLIK, S.D. (1988), Further evidence
for the existence of AIDS in the pre-AIDS era. Rev. infect. Dis.,
10, 1061.
HUSSEY, H. & KATZ, S. (1950), Infections resulting
from narcotic addiction. Amer. J. Med., 9, 186-193.
JAFFE, H.W., CHOI, K., THOMAS, P.A., et al. (1983),
National case-control study of Kaposi's sarcoma and Pneumocystis carinii
pneumonia in homosexual men. I. - Epidemiological results. Ann. Intern.
Med., 99, 145-151.
JIN, Z., CLEVELAND, R.P. & KAUFMAN, D.B. (1989), Immunodeficiency
in patients with hemophilia: an underlying deficiency and lack of correlation
with factor replacement therapy or exposure to human immunodeficiency virus.
J. Allergy clin. Immunol., 83, 165-170.
KACKER, P.P. (1973), A case of Giardia lamblia proctitis
presenting in a VD clinic. Brit. J. Vener. Dis., 49, 318-319.
KAPLAN, J., SARNAIK, S., GITLIN, J. & LUSHER, J. (1984),
Diminished helper/suppressor lymphocyte ratios and natural killer activity
in recipients of repeated blood transfusions. Blood, 64, 308-310.
KATNER, H.P. & PANKEY, G.A. (1987), Evidence for a
Euro-American origin of human immunodeficiency virus (HIV). J. nat.
Med. Ass., 79, 1068-1072.
KAZAL, H.L., SOHN, N., CARRASCO, J.I., et al. (1976),
The gay bowel syndrome: clinico-pathological correlation in 260 cases.
Ann. Clin. Lab. Science, 6, 184-192.
KEAN, B.H. (1976), Venereal amebiasis. N. Y. St. J.
Med., 76, 930-931.
KINNEY, T.F. (1942), Intranuclear inclusions in infancy.
Amer. J. Path.,18, 799-807.
KINSEY, A.C., POMEROY, W.B. & MARTIN, C.E. (1948),
Sexual behavlor in the human male. W.B. Saunders, Philadelphia.
KLEMOLA, E., STENSTROM, R. & VON ESSEN, R. (1972),
Pneumonia as a clinical manifestation of cytomegalovirus infection in previously
healthy adults. Scand. J. inject. Dis., 4, 7-10.
KNIGHT, A., O'BRIEN, P. & OSOBA, D. (1972), "Spontaneous"
progressive multifocal leukoencephalopathy. Immunologic aspects. Ann.
Intern. Med., 77, 229-233.
LARSON, A.A. (1959), The transmission of venereal disease
through homosexual practices. Canad. Med. Ass. J., 80, 22.
LEVINE, R.S., WARNER, N.E. & JOHNSON, C.F. (1964),
Cytomegalic inclusion disease in the gastrointestinal tract of adults.
Ann. J. Surg., 159, 37-48.
LEMAITRE, M., GUÉTARD, D., HÉNIN, Y., MONTAGNIER,
L. & ZERIAL, A. (1990), Protective activity of tetracycline analogs
against the cytopathic effect of the human immunodeficiency virus in CEM
cells. Res. Virol., 141, 5.
LINDBOE, C.F., FROLAND, S.S., WEFRING, K.W., LINNESTAD,
P.J., et. al. (1986), Autopsy findings in three family members with
a presumably acquired immunodeficiency syndrome of unknown etiology. Acta
Path. Microbiol. Immunol. scand. (Sect A) 94, 117-123.
LITTMAN, M.L. & WALTER, J.E. (1968), Cryptococcosis:
current status. Amer. J. Med., 45, 922-932.
LO, S.-C. (1986), Isolation and identification of a novel
virus from patients with AIDS. Amer. J. trop. Med. Hyg., 35, 675-676.
LO, S.-C., DAWSON, M.S., WONG, D.M., NEWTON, P.W. III,
et al. (1989), Identification of Mycoplasma incognitus infection
in patients with AIDS: an immunohistochemical, in situ hybridization and
ultrastructural study. Amer. J. trop. Med. Hyg., 41, 601-616.
LORIAN, V. (1988), AIDS, anal sex, and heterosexuals.
Lancet, I, 111 I .
LOTZOVA, E., SAVARY, C.A., HERSH, E.M., KHAN, A.A. &
ROSENBLUM, M. (1984), Depression of murine natural killer cell cytotoxicity
by isobutyl nitrite. Cancer Immunol. lmmmmunother., 17, 130-134.
LOURIA, D.B., HENSLE, T. & ROSE, J. (1967), The major
medical complications of heroin addiction. Ann. Intern. Med., 67,
1-22.
LOWDELL, C.P. & GLASER, M.G. (1989), Long term survival
of male homosexual patients with Kaposi's sarcoma. J. R. Soc. Med.,
82, 226-227.
LUSSO, P., ENSOLI, B., MARKHAM, P.D. et al. (1989),
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6.
Nature (Lond.), 337, 370-373.
LUSSO, P., VERONESE, F.M., ENSOUL, B., et al. (1990),
Expanded HIV-1 cellular tropism by phenotypic mixing vwith murine endogenous
retroviruses. Science, 247, 848-852.
MACPHERSON, B.R., et al. (1981), Alloimmunization
to public HLA antigens in multi-transfused platelet recipients. Ann.
clin. Lab. Sci., 16, 38-44.
MARINO, A.W.M. (1964), Proctologic lesions observed in
male homosexuals. Dis. Colon Rectum, 7, 121-128.
MARMOR, M., FRIEDMAN-KIEN, A.E., LAUBENSTEIN, L., et
al. (19ó2), Risk factors for Kaposi's sarcoma in homosexual
men. Lancet, I, 1083-1087.
MAROTTA, T. (1981), The politics of homosexuality. Houghton
Mifflin, Boston.
MATHEWS, T., WISOTZKEY, H. & MOOSY, J. (1976), Multiple
central nervous system infections in progressive multifocal leukoencephalopathy.
Neurology, 26, 9-14.
MATHUR, S., GOUST, J.-M., WILLIAMSON, H.O., et al.
(1981), Cross-reactivity of sperm and T-lymphocyte antigens. Amer. J.
Reprod. Immunol., 1, 113-118.
MAVLIGIT, G.M., TALPAZ, M., HSIA, F.T., et al.
(1984), Chronic immune stimulation by sperm alloantigens. Support for the
hypothesis that spermatazoa induce immune dysregulation in homosexual males.
J. Amer. med. Ass., 251, 237-241.
McDONOUGH, R.J., MADDEN, J.J., FALEK, A., et al.
(1980), Alteration of T and null lymphocyte frequencies m the peripheral
blood of human opiate addicts: in vivo evidence for opiate receptor sites
on T lymphocytes. J. Immunol., 125, 2539.
MEDEARIS, D.N. (1957), Cytomegalic inclusion disease.
Pediatrics, 19, 467-480.
MELLA, B. & LANG, D.J. (1967), Leucocyte mitosis:
suppression in vitro associated with acute infectious hepatitis. Science,
155, 80-81.
MEYERS, J.D., KUHARIC, J.A. & HOLMES, K.K. (1977),
Giardia lamblia infection in homosexual men. Brit. J. Vener. Dis.,
53, 54-55.
MILDVAN, D., GELB, A.M. & WILLIAM, D. (1977), Venereal
transmission of enteric pathogens in male homosexuals. Two case reports.
J. Amer. med. Ass., 238, 1387-1389.
MILLER, B., STANSFIELD, S.K., ZACK, M.M., et al.
(1984), The syndrome of unexplained generalized lymphadenopathy in young
men in New York City. J. Amer. med. Ass., 251, 242-246.
MONGIN, M., et al. (1979), Kaposi's sarcoma simulating
a splenolymphatic lymphoma, toxoplasmosis, and terminal cryptococcus infection.
Ann. Med. Int. (Paris), 130, 625-629.
MOSKOWITZ, L.B., HENSLEY, G.T., CHAN, J.C., GREGORIOS,
J. & CONLEY, F.K. (1984), The neuropathology of acquired immune deficlency
syndrome. Arch.Path. Lab. Med. 108, 867-872.
MOST, H. (1968), Manhattan: "A tropic isle?"
Amer. J. trop. med. Hyg., 17, 333-354.
MUNSTER, A.M., LOADHOLDT, C.B., LEARY, A.G. & BARNES,
M.A. (1977), The effect of antibiotics on cell-mediated immunity. Surgery,
81, 692-696.
MURET, M.P.G., SORIANO, V., PUJOL, R.M., HEWLETT, I.,
CLOTET, B. & DE MORAGAS, J.M. (1990), AIDS and Kaposi sarcoma in HIV-negative
bisexual man. Lancet, I, 969-970.
NAKAH, A.E., FRANK, O., LOURIA, D.B., GUINONES, M.A. &
BAKER, H. (1979), A vitamin profile of heroin addiction. Amer. J. publ.
Hlth, 69, 1058-1060.
NAHMIAS, A.J., WEISS, J., YAO, X., LEE, F., et al.
(1986), Evidence for human infection with an HTLVIII-LAV-like virus in
central Africa, 1959. Lancet, I, 1279-1280.
NEWELL, G.R., MANSELL, P.W.A., SPITZ, M.R., RUEBEN, J.M.
& HERSH, E.M. (1985), Volatile nitrites. Use and adverse effects related
to the current epidemic of the acquired immune deficiency syndrome. Amer.
J. Med., 78. 811-816.
OILL, P.A., FIALA, M., SHOFFERMAN, J., BYFIELD, P.A. &
GUZE, L.B. (1977) Cytomegalovirus mononucleosis in a healthy adult. Association
with hepatitis, secondary Epstein-Barr virus antibody response and immunosuppression.
Amer. J. Med. 62, 413-417.
PANKHURST, C. & PEAKMAN, M. (1989), Reduced CD4+ T
cells and severe oral candidiasis in absence of HIV infection. Lancet,
I, 672.
PAPADOPOULOS-ELEOPULOS, E. (1988), Reappraisal of AIDS.
Is the oxidation induced by the risk factors the primary cause ? Med.
Hypotheses, 25, 151-162 .
PETERMAN, T.A., STONEBURNER, R.L., ALLEN, J.R., JAFFE,
H.W. & CURRAN, J.WW. (1988), Risk of human Immunodeficiency virus transmission
from heterosexual adults with transfusion-associated infections. J.
Amer. med. Ass., 259, 55-58.
PIFER, L.L., WANG, Y.-F., CHIANG, T.M., AHOKAS, R., WOODS,
D.R. & JOYNER, R.E. (1987), Borderline immunodeficiency in male homosexuals
: Is life-style contributory? South. Med. J., 80, 687-697.
POLLACK, S., ATIAS, D., YAFFE, G., KATZ, R., SCHECHTER,
Y. & TATARSKY, I. (1985), Impaired immune function in hemophilia patients
treated exclusively with ctyoprecipitate: relation to duration of treatment.
Amer. J. Hematol., 20,1.
PROKNOW, J.J., BENFIELD, J.R., RIPPON, J.W., DIENER, C.F.
& ARCHER, F.L. (1965), Cryptococcal hepatitis presenting as a surgical
emergency. J. Amer. med. Ass., 191, 269.
RICHARDSON, E.P., Jr (1961), Progressive multifocal leukoencephalopathy.
New Engl. J. Med., 265, 815.
ROCKWELL, D., RUBEN, F.L., WINKELSTEIN, A. & MENDELOW,
H. (1976), Absence of immune deficiencies in a case of progressive multifocal
leukoencephalopa-thy. Amer. J. Med., 61, 433-436.
Root-Bernstein, R.S. (1990a), Multiple-antigen-mediated
autoimmunity (MAIsMA) in AIDS: a possible model for post-infectious autoimmune
compltcations. Res. Immunol., 4-5, 321-340.
ROOT-BERNSTEIN, R.S. (1990b), Do we know the cause(s)
of AIDS? Persp. Biol. Med., 33, 480-500.
ROOT-BERNSTEIN, R.S. (1990c), AIDS and Kaposi's sarcoma
pre-1979. Lancet, I, 969.
ROUSE, B.T. & HOROHOV, D.W. (1986), Immunosuppression
in viral infections. Rev. infect. Dis., 6, 850-873.
RUBIN, H. (1988), Etiology of AIDS. Science, 241,
1389-1390.
RuecN, H. & FURCOLOW, M.L. (1958), Promising results
in cryptococcal meningitis. Neurology, 8, 590.
SABESIN, S.M., FALLON, H.J. & ANDRIOLE, V.T. (1963),
Hepatic failure as manifestation of cryptococcosis. Arch. Intern. Med.
111, 661.
SALVETElRRA, O., VICENT, T., AMKEND, W., et al.
(1980), Deliberate donor-specific blood transfusions prior to living-related
renal transplantation: a ness approach. Ann. Surg., 192, 543-552.
SAPIRA, J.D. (1968), The narcotic addict as a medical
patient. Amer. J. Med., 45, 555-588.
SCHIMPF, S.C. & BENNETT, J.E. (1975), Abnormalities
in cell-mediated immunity in patients with Cryptococcus neoformans infection.
J. Allergy Clin. Immunol., 55, 430-441.
SCHMERIN, M.J., GELSTON, A. & JONES, T.C. (1977),
Amebiasis: an increasing problem among homosexuals in New York City.
J. Amer. med. Ass., 238, 1386-1387.
SCHREEDER, M.T., THOMPSON, S.E., HADLER, S.C., et al.
(1982), Hepatitis B in homosexual men: prevalence of infection and factors
related to transmission. J. infect. Dis., 146, 7-15.
SHIRATSUCHI, H. & TSUYUGUCHI, I. (1984), Analysis
of T-cell subsets studied by monoclonal antibodies in patients with tuberculosis
after in vitro stimulation with purified protein derivative of tuberculin.
Clin. exp. Immunol., 57, 271.
SILVERMAN, L. & RUBINSTEIN, L.J. (1965) Electron microscopic
observations on a case of progressive multifocal leukoencephalopathy. Acta
neuropatlm. (Berl.), 5, 215.
SMITH, C.B. (1985), Candidiasis: pathogenesis, host resistance,
an predisposing factors, in "Candidiasis" (G.P. Body and
V. Fainstein) (pp. 53-70). Raven Press, New York.
SMITH, J.L. (1959), Progressive multifocal leukoencephalopathy.
Arch. Ophthal., 62, 828.
SMITH, T.F., HOLLEY, K.E., KEYS, T.F. & MACASAET,
F.F. (1975), Cytomegalovirus studies of autopsy tissue. l. - Virus isolation.
Amer. clin. Path., 63, 854-858.
SMOLAR, E.N., PRYJMA, P.J. & BERGER, S. (1975), Cytomegalovirus
infection in a heroin addict. N.Y. St J. Med., 75, 406.
SOHN, N., WEINSTEIN, M.A. & GONCHAR, J. (1977), Social
injuries of the rectum. Amer. J. Surg., 134, 611-612.
SONNABEND, J.A. (1989), AIDS: an explanation for its occurence
among homosexual men. in "AIDS and opportunistic infections of homosexual
men". (Ma, P. & Armstrong, D.) (pp. 449-470). Butterworth, Stoneham,
Massachusetts.
SONNABEND, J.A., WITKIN, S.S. & PORTILO, D.T. (1984),
A multifactorial model for the development of AIDS in homosexual men. Ann.
N.Y. Acd. Sci., 837, 177-183.
SPICKARD, A., BUTLER, W.T., ANDRIOLE, V. & UTZ, J.P.
(1963), The improved prognosis of cryptococcal meningitis with amphotericin
B therapv.. Ann. Intern. Med., 58, 66-83.
SZMUNESS, W., MucH, M.I., PINCE, A.M., et al. (197S),
On the role of sexual behavior in the spread of hepatitis B infection.
Ann. Intern. Med., 83, 489-495.
TARR, J.D. & LUGAR, R.R. (1960), Early infectious
syphilis: male homosexual relations and mode of spread. California Med.,
93, 35.
THOMAS, F.T., CRAVER, F.M., FOIL, M.B., et al. (1983),
Long-term incompatible kidney survival in outbred higher primates without
chronic immunosuppression. Ann. Surg., 198, 370-378.
TILLOTSON, J.R. & LERNER, A.M. (1965), Prostatism
in an eighteen year old boy due to infection with cryptococcal neoformans.
New Engl. J. Med., 273,1150.
TSUDA, T. & KAHAN, B.D. (1983), The effects of anesthesia
on the immune response, in "Primary and secondary immunodeficiency
disorders. (R.K. Chandra) (pp. 253-262). Churchill Livingston, Edinburgh.
USDHHS (1985), Patterns and trends in drug abuse: a national
and international perspective, Washington, D.C., Div. of Epidemiology and
Statistical Analysis, National Institute on Drug Abuse.
VAISRUB, S. (1977), Homosexuality - a risk factor in infectious
disease. J. Amer. med. Ass., 238, 1402.
VERSE, M. (1914), Über einen Fall von generale sierter
Blastomykose beim Menschen. Verh. Deutsch Ges. Path., 17, 275.
VON GLAHN, W.C. & PAPPENHEIMER, A.M. (1925), Intranuclear
inclusions in visceral disease. Amer. J. Path., 1, 445-466.
WARD, J.W., BUSH, T.J., PERKINS, H.A., LIES, L.E., et
al. (1989), The natural history of transfusion-associated infection
with human immunodeficiencyvirus. New Eng. J. Med., 321, 947-952.
WEBER, R.J. & PERT, A. (1989), The periaqueductal
gray matter mediates opiate induced immunosuppression. Science,
245, 188-190.
WEBSTER, A., LEE, C.A., COOK, D.G., et al. (1989),
Cytomegalovirus infection and progression towards AIDS in haemophiliacs
with human immunodeficiency virus infection. Lancet, II, 63-66.
WEIGLE, K.A., et al. (1983), Changes in T-lymphocyte
subsets during childhood Epstein-Bacr virus infectious mononucleosis. J.
Clin. Imnunol., 3, 15l.
WEINER, L.P., HERNDON, R.M., NARAYAN, O., JOHNSON, R.T.,
SHAH, K., et al. (1972), Isolation of virus related to SV4O from
patients with progressise multifocal leukoencephalopathy. New Engl.
J. Med., 286, 385-390.
WEINSTEIN, M.A., SOHN, N. & ROBBINS, R.D. (1981),
Syndrome of pelvic cellulitis following rectal sexual trauma. Amer.
J. Gastroenter., 75. 380-381.
WEINSTEIN, V.F., WOOLF, A.L. & MEYNELL, M.J. (1963),
Progressive multifocal leucoencephalopathy and primary hypersplenism. J.
Clin. Path., 26, 405.
WITTE, M.H., WITTE, C.L., MINNICH, L.L., et al.
(1984), AIDS in 1968. J. Amer. med. Ass. 251, 2657.
WONG, T.-W. & WARNER, N.E. (1962), Cytomegalic inclusion
disease in adults. Arch. Path., 74, 403-422.
WRIGHT, K. (1990), Mycoplasmas in the AIDS spotlight.
Science 248, 682-683.
YARDLEY, J.H. & HENDRIX, T.R. (1980), Immunologic
status in patients ywith giardiasis. Gastroenterology, 78, 42I-422.
*
VIRUSMYTH HOMEPAGE